Cargando…
Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657613/ https://www.ncbi.nlm.nih.gov/pubmed/37980526 http://dx.doi.org/10.1186/s12951-023-02199-1 |
_version_ | 1785148181646934016 |
---|---|
author | Kiaie, Seyed Hossein Salehi‑Shadkami, Hossein Sanaei, Mohammad Javad Azizi, Marzieh Barough, Mahdieh Shokrollahi Nasr, Mohammad Sadegh Sheibani, Mohammad |
author_facet | Kiaie, Seyed Hossein Salehi‑Shadkami, Hossein Sanaei, Mohammad Javad Azizi, Marzieh Barough, Mahdieh Shokrollahi Nasr, Mohammad Sadegh Sheibani, Mohammad |
author_sort | Kiaie, Seyed Hossein |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10657613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106576132023-11-18 Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy Kiaie, Seyed Hossein Salehi‑Shadkami, Hossein Sanaei, Mohammad Javad Azizi, Marzieh Barough, Mahdieh Shokrollahi Nasr, Mohammad Sadegh Sheibani, Mohammad J Nanobiotechnology Correction BioMed Central 2023-11-18 /pmc/articles/PMC10657613/ /pubmed/37980526 http://dx.doi.org/10.1186/s12951-023-02199-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Kiaie, Seyed Hossein Salehi‑Shadkami, Hossein Sanaei, Mohammad Javad Azizi, Marzieh Barough, Mahdieh Shokrollahi Nasr, Mohammad Sadegh Sheibani, Mohammad Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title | Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title_full | Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title_fullStr | Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title_full_unstemmed | Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title_short | Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
title_sort | correction: nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657613/ https://www.ncbi.nlm.nih.gov/pubmed/37980526 http://dx.doi.org/10.1186/s12951-023-02199-1 |
work_keys_str_mv | AT kiaieseyedhossein correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT salehishadkamihossein correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT sanaeimohammadjavad correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT azizimarzieh correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT baroughmahdiehshokrollahi correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT nasrmohammadsadegh correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy AT sheibanimohammad correctionnanoimmunotherapyovercomingdeliverychallengeofimmunecheckpointtherapy |